iDNA Genomics Public (CYS:IDNA) Buildings And Improvements : €0.00 Mil (As of . 20)

View and export this data going back to 2021. Start your Free Trial

What is iDNA Genomics Public Buildings And Improvements?

iDNA Genomics Public Buildings And Improvements Historical Data

The historical data trend for iDNA Genomics Public's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iDNA Genomics Public Buildings And Improvements Chart

iDNA Genomics Public Annual Data

Trend

Buildings And Improvements

iDNA Genomics Public Semi-Annual Data

Buildings And Improvements

iDNA Genomics Public Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

iDNA Genomics Public Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » iDNA Genomics Public Ltd (CYS:IDNA) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

N/A

Address

Evrota 25- 27, Kifissia, GRC, 145 64

Website

https://www.idnagenomics.com

iDNA Genomics Public Ltd is engaged in performing precision medicine and genetic analysis (DNA Tests). Its focus is on developing and providing Genetic Testing Analysis both in Medical and Direct-To-Consumer Genomics sectors, with research activity through cooperation with universities in Greece and abroad.